According to our tracking of OGD approvals for March 2017 through the daily listings of approvals on Drugs@FDA: FDA Approved Drug Products (which was fairly close to the final numbers last month), there appears likely to be 59 full ANDA approvals and 16 tentative approvals reported when OGD issues final numbers in its Activities Report of the Generic Drug Program in a few days.
These numbers appear consistent with the monthly figures seen in previous months so far in FY 2017, and when the official tally is posted, we will update these figures, if necessary, and provide some yearly projections for both approval actions and ANDA receipts. Sit tight, we will be right back with those numbers as soon as they are published.
